NL6616277A - - Google Patents

Info

Publication number
NL6616277A
NL6616277A NL6616277A NL6616277A NL6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A
Authority
NL
Netherlands
Application number
NL6616277A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6616277A publication Critical patent/NL6616277A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL6616277A 1965-11-19 1966-11-18 NL6616277A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1598865A CH474486A (de) 1965-11-19 1965-11-19 Verfahren zur Herstellung neuer Diphenylharnstoffe
CH1409266 1966-09-29

Publications (1)

Publication Number Publication Date
NL6616277A true NL6616277A (xx) 1967-05-22

Family

ID=25713607

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6616277A NL6616277A (xx) 1965-11-19 1966-11-18

Country Status (11)

Country Link
US (2) US3560566A (xx)
AT (1) AT269166B (xx)
BE (1) BE689902A (xx)
BR (1) BR6684680D0 (xx)
CH (1) CH474486A (xx)
DE (1) DE1568349A1 (xx)
DK (1) DK118457B (xx)
FR (3) FR1504097A (xx)
GB (1) GB1142066A (xx)
NL (1) NL6616277A (xx)
SE (1) SE323360B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311432A (en) * 1971-01-07 1973-03-28 Ici Ltd Guanidine derivatives their preparation and antiviral compositions containing them
DE3360148D1 (en) * 1982-02-10 1985-06-05 Beecham Group Plc Guanidine derivatives
US5238941A (en) * 1988-03-25 1993-08-24 Ciba-Geigy Corporation Arylhydrazones and pharmaceutical compositions thereof
US4971986A (en) * 1988-03-25 1990-11-20 Ciba-Geigy Corporation Arylhydrazones useful as SAMDC inhibitors
US6008255A (en) * 1994-01-21 1999-12-28 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
WO2002000613A2 (en) * 2000-06-27 2002-01-03 Axxima Pharmaceuticals Ag Inhibitors of hepatitis b virus infection
US20050282909A1 (en) * 2003-11-14 2005-12-22 Diks Sander H Guanylhydrazones in methods of treatment or diagnosis as modulators of signal transduction
DK1778265T3 (da) * 2004-08-17 2013-06-24 Ferring Bv Guanylhydrazoneforbindelser, sammensætninger, fremgangsmåder og anvendelse
EP1912635B1 (en) * 2005-07-29 2014-03-05 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Use of chk2 kinase inhibitors for cancer treatment
EP2155675B1 (en) 2007-06-12 2014-02-19 Provid Pharmaceuticals, Inc. Kinase inhibitors, compositions thereof, and methods of use therewith
US20160152560A1 (en) * 2013-05-28 2016-06-02 The Regents Of The University Of California Compounds for the treatment of hypertension and hypertensive end stage renal disease

Also Published As

Publication number Publication date
BR6684680D0 (pt) 1973-12-18
DK118457B (da) 1970-08-24
US3560557A (en) 1971-02-02
CH474486A (de) 1969-06-30
AT269166B (de) 1969-03-10
FR6139M (xx) 1968-06-24
US3560566A (en) 1971-02-02
FR1504097A (fr) 1967-12-01
DE1568349A1 (de) 1970-02-12
GB1142066A (en) 1969-02-05
SE323360B (xx) 1970-05-04
BE689902A (xx) 1967-05-18
FR6153M (xx) 1968-07-01

Similar Documents

Publication Publication Date Title
BE673125A (xx)
BE675324A (xx)
AU416352B2 (xx)
BE675369A (xx)
AU6783465A (xx)
BE658564A (xx)
BE663771A (xx)
BE664767A (xx)
BE665744A (xx)
BE668297A (xx)
BE668917A (xx)
BE669447A (xx)
BE675426A (xx)
BE669636A (xx)
BE671240A (xx)
BE671348A (xx)
BE671386A (xx)
BE671387A (xx)
BE671454A (xx)
BE671749A (xx)
BE671856A (xx)
BE672238A (xx)
BE672778A (xx)
BE672840A (xx)
BE675421A (xx)